Year Book of Endocrinology® 2009
Edited by Matthias Schott, MD, PhD, associate professor and deputy director of the Department of Endocrinology, Diabetology, and Rheumatology at the University Hospital of Duesseldorf in Germany, and eight other associate editors, the Year Book of Endocrinology 2009 includes the breakthrough developments in endocrinology selected from more than 500 journals worldwide and consists of nine sections: Diabetes, Lipoproteins and Atherosclerosis, Obesity, Thyroid, Calcium and Bone Metabolism, Reproductive Endocrinology, Neuroendocrinology, and Pediatric Endocrinology.
Each section contains summaries of selected articles, followed by editorial comments that further clarify the importance of each article and discuss its application for practicing physicians. Each section also contains an introduction by one of the associate editors, each of whom is an expert in his or her field.
Each selected article is included and evaluated in the hopes that it will provide insight into endocrine problems faced by physicians in everyday practice. The 2009 editor’s choice article is “Motesanib diphosphate in progressive differentiated thyroid cancer,” published in The New England Journal of Medicine by Sherman et al. The article focuses on the use of motesanib diphosphate, platelet-derived growth-factor receptor, and KIT in poorly differentiated thyroid cancers.
Section 7: Reproductive Endocrinology is edited by A. Wayne Meikle, MD, professor of medicine and pathology at the University of Utah School of Medicine and medical director of Endocrinology & Automated Endocrinology laboratories at ARUP Laboratories, and consists of seven topics: PCOS, Estrogen and Coronary Artery Disease, Female Replacement Therapy, Female Reproductive Function and Menopause, Bone Health in Men, Hypogondism and Aging, and Metabolic Syndrome and Hypogondism. In the introduction to this section and comments on each selected article, Dr. Meikle shares his expertise in the area of reproductive endocrinology, discussing obesity’s effect on hormone secretion and other endocrine organs, hormonal replacement therapy, hypothalamic hypoestrogenemia, and osteoporosis, among others.